Promising Schizophrenia Drug, Cobenfy, Will Likely Face Access Challenges
Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...
Hosted on MSN1mon
FDA approves a novel drug for schizophrenia, a potential ‘game changer’
He was responsible for launching the company’s last major drug to treat schizophrenia, the antipsychotic Abilify, in 2002. Cobenfy, set to launch in October, will have a list price that would ...
Taking drugs like LSD and ecstasy can increase your risk of schizophrenia, according to new study
Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...
Fox News1mon
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...
Verywell Health on MSN1mon
Cobenfy: The First New Schizophrenia Drug in Decades
BMS said Cobenfy will be available in October at a list price of $1,850 per month ... the price is in line with other ...
STAT1mon
Why I’m wary of the new schizophrenia miracle drug
Historically, powerful people rarely invest in new medications for marginalized populations like those with schizophrenia. When it happens, it feels like the system is finally listening to us ...
Medical News Today21d
Caplyta side effects: What you should know
More common side effects in people taking Caplyta for schizophrenia include: Mild side effects can occur with Caplyta use. This list doesn’t include all possible mild side effects of the drug.
Yahoo1mon
FDA approves 1st new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb, combines ...